Daulat Medical Cost Intelligence Tool
Sample · Anonymised
CEO & Board Strategic Brief

A well-priced claims base, growing too fast.

Malaysian employer · 12 months of claims
1.8×
Claims growth vs medical inflation.
79%
Of burden in three conditions.
3
People drive 60% of top-tier spend.
~1 in 10
Employees with undiagnosed NCDs.
The read in one line

Cost discipline is real, but the curve is compounding well above the market, and most of it sits in a handful of cases nobody is managing.

Three moves

  1. 1 Put healthcare cost on the risk register.A cost that compounds belongs with your other P&L risks.
  2. 2 Manage the outlier cases within 90 days.Targeted care, not broad wellness. Duty of care, documented.
  3. 3 Treat pharmacy as procurement.Generic substitution in 30–60 days, and a TPA paid to save, not spend.
What the full brief adds
Ringgit values per move, a three-year cost trajectory, case-level profiles and board questions.
Recommended next step
A fixed-fee, 90-day intervention engagement with board reporting.